261 results found.
                    
2018 Year in Review: Revenue Projections and Technology Trends
By Mike Evers In November, we published our downloadable report, 2018 Revenue Projections: Companies Over $200 Million, for the 25 largest orthopaedic companies, shown here in Exhibit 1. Sales for these 25 companies account for approximately 80% of the worldwide orthopaedic market. We p...
ChoiceSpine Acquired by Altus Capital
ChoiceSpine, a manufacturer of devices and biologics used to treat complex spine disorders, was acquired by Altus Capital Partners.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
Spine Merger & Acquisition Activity Going Strong
By Julie A. Vetalice Updated September 2018 to include additional transactions from 3Q18. Throughout 2017 and thus far in 2018, players of all sizes in the spine segment have taken a variety of steps to fill portfolio gaps, bolster growth and remain competitive. ...
ExactechGPS Used in First Total Knee Revision with Truliant Knee
ExactechGPS® revision knee software and Exactech's Truliant® Knee system instrumentation were...
Wright Medical Announces 1Q18 Revenue
Wright Medical reported 1Q18 revenue of US $198.5MM, +12.0% from 1Q17.
Exactech Granted FDA Clearance for Vitamin E Acetabular Polyethylene Liner
Exactech received FDA 510(k) clearance to market Novation XLE Vitamin E acetabular polyethylene liners for hip r...
Exactech Receives FDA Clearance for Equinoxe Stemless Shoulder
Exactech received FDA 510(k) clearance to market the Equinoxe® Stemless Shoulder for total shoul...
Recapping Your Predictions: Consolidations and Launches as Growth Opportunities
At the dawn of 2017, we published results of an ORTHOWORLD Membership survey in ORTHOKNOW. Among the questions, we asked you to predict: In 2017, where do the opportunities lie for you and your company? Your responses included new product launches; patient-specific implants and instrume...
AAOS 2018 First-Time Exhibitors Emphasize Navigation, Orthobiologics, Outcomes
By Julie A. Vetalice In examining the list of AAOS 2018 exhibitors, I see that a number of first-time exhibiting OEMs offer either orthobiologics or navigation…I’m not surprised, as it’s rare for a “new” hip or knee replacement device company to appear, an...
The Orthopaedic Products and Services of 2017
By Julie A. Vetalice The annual rundown of products and services is like attending a reunion—we’re looking back over the year and keeping you informed on what everyone is doing. Here’s what made headlines with market entry in 2017. We’ll start with services, and ...
First Surgery with Exactech Vantage Mobile Bearing Total Ankle
Exactech announced successful completion of the first surgery using the Vantage® Total Ankle Mobile Beari...
Majority of Public Orthopaedic Companies Still on Track for Full-Year Guidance
By Julie A. Vetalice Looking at 3Q17 revenue and reading call transcripts, much was said about unforeseen headwinds that crept in before the close of the year, affecting orthopaedic companies in a variety of ways. Following weather events, oft-cited “softness&rdqu...
Exactech Posts 3Q17 Revenue Growth
Exactech posted 3Q17 revenue of US $61.4MM, +2.6% vs. 3Q16, and YTD revenue of $198.2MM, +3.6% vs. the prior ...
Exactech Truliant Instrumentation Used in Knee Revision
Exactech announced completion of the first revision knee procedure with Truliant® instrumentation.
Exactech to Become Privately-Held Company
Via terms of a definitive agreement with TPG Capital, Exactech is slated to become a privately-held company in ...
Sales Results for 20 Orthopaedic Companies: A Mid-year Status Report
By Julie A. Vetalice Now that we’ve collected 1H17 results from 20 publicly-traded companies, I’d like to share some performance-based observations. With now just 4 months remaining in the year, these companies provide a helpful gauge in projecting industry growth.
Exactech Posts 2Q17 Revenue
Exactech posted 2Q17 revenue of US $67.3MM, +1.8% vs. 2Q16, and 1H17 revenue of $136.8MM, +4.1% vs. 1H16.
Top Orthopaedic Device Companies: Ranking #6 to #15
Update: 2017 revenue for the 20 largest orthopaedic device companies can be found in the latest installment of  THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
Exactech Expands ExactechGPS Portfolio with Total Knee Application
Exactech announced first surgery with ExactechGPS® TKA PLUS for total knee reconstruction.
ChoiceSpine Launches Biologics Portfolio
ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware portfolio.
New Exactech Joint Recon Systems Used in Japan
Exactech announced the first clinical use in Japan of recently-approved systems for shoulder, knee and hip reconstruction.
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
First Procedures with Exactech's Alteon HA Femoral Hip Stem
Exactech completed initial surgeries with the Alteon® HA Femoral Hip stem.
First Procedure with Exactech's Equinoxe Preserve Shoulder Stem
Exactech announced the first surgery with the Equinoxe® Preserve humeral stem and first ...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2018 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group